Key points are not available for this paper at this time.
T cells in Her2-enriched and Basal-like subtypes. In conclusion, our findings demonstrate significant differences in the immune tumor microenvironment between the established breast cancer molecular subtypes.
Torland et al. (2026) studied this question.